Subscribe to RSS
DOI: 10.1055/s-0036-1585063
Treatment of Atypical Evolutions of Idiopathic Focal Epilepsies in Childhood
Publication History
25 March 2016
14 April 2016
Publication Date:
01 July 2016 (online)
Abstract
The relationship between continuous spike-and-wave discharges during slow sleep (CSWSS) and neuropsychological impairment (cognitive functions, memory consolidation, and language and behavior disturbances) has been clearly demonstrated. These phenomena occur not only in symptomatic cases of CSWSS or electrical status epilepticus in sleep (ESES) syndrome, but also in the different conditions that constitute the spectrum of atypical evolutions of idiopathic focal epilepsies of childhood (IFEC). In spite of continuous advances in treatment, management is still difficult and challenging. Treatment options of atypical evolutions of IFEC include benzodiazepines, sulthiame, levetiracetam, valproic acid, and ethosuximide. Other drugs such as lacosamide and acetazolamide have been proposed. Usual antiepileptic drugs such as carbamazepine, phenobarbital, phenytoin, oxcarbazepine, lamotrigine, and topiramate were proven to be capable of inducing ESES. Steroids and intravenous immunoglobulins were recommended in refractory cases. Surgery, ketogenic diet, and vagal nerve stimulation were also used in some cases. Our interest regarding a scheme of treatment in atypical evolutions of IFEC is centered on two questions: (1) Is it possible to prevent the evolution of IFEC into atypical focal epilepsies of childhood, status epilepticus of IFEC, Landau–Kleffner's syndrome, or ESES syndrome? (2) Which is the treatment of choice once one of these conditions is installed?
-
References
- 1 Fejerman N, Caraballo R. Benign Focal Epilepsies in Infancy, Childhood and Adolescence. London: John Libbey Eurotext; 2007
- 2 Sánchez Fernández I, Chapman KE, Peters JM, Harini C, Rotenberg A, Loddenkemper T. Continuous spikes and waves during sleep: electroclinical presentation and suggestions for management. Epilepsy Res Treat 2013; 2013: 583531
- 3 Veggiotti P, Pera MC, Teutonico F, Brazzo D, Balottin U, Tassinari CA. Therapy of encephalopathy with status epilepticus during sleep (ESES/CSWS syndrome): an update. Epileptic Disord 2012; 14 (1) 1-11
- 4 Caraballo R, Fontana E, Michelizza B. CBZ inducing atypical absences, drop-spells and continuous spike and waves during slow sleep (CSWS). Boll Lega It Epil 1989; 66/67: 379-381
- 5 Guerrini R, Dravet C, Genton P , et al. Epileptic negative myoclonus. Neurology 1993; 43 (6) 1078-1083
- 6 Fejerman N, Caraballo R, Tenembaum SN. Atypical evolutions of benign localization-related epilepsies in children: are they predictable?. Epilepsia 2000; 41 (4) 380-390
- 7 Kikumoto K, Yoshinaga H, Oka M , et al. EEG and seizure exacerbation induced by carbamazepine in Panayiotopoulos syndrome. Epileptic Disord 2006; 8 (1) 53-56
- 8 Guerrini R, Belmonte A, Strumia S, Hirsch E. Exacerbation of epileptic negative myoclonus by carbamazepine or phenobarbital in children with atypical benign rolandic epilepsy. Epilepsia 1995; 36 (Suppl. 03) S65
- 9 Guerrini R, Belmonte A, Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia 1998; 39 (Suppl. 03) S2-S10
- 10 Saltik S, Uluduz D, Cokar O, Demirbilek V, Dervent A. A clinical and EEG study on idiopathic partial epilepsies with evolution into ESES spectrum disorders. Epilepsia 2005; 46 (4) 524-533
- 11 Prats JM, Garaizar C, García-Nieto ML, Madoz P. Antiepileptic drugs and atypical evolution of idiopathic partial epilepsy. Pediatr Neurol 1998; 18 (5) 402-406
- 12 Prats-Viñas JM. Complicated benign partial epilepsy [in Spanish]. Rev Neurol 2002; 35 (1) 73-79
- 13 Catania S, Cross H, de Sousa C, Boyd S. Paradoxic reaction to lamotrigine in a child with benign focal epilepsy of childhood with centrotemporal spikes. Epilepsia 1999; 40 (11) 1657-1660
- 14 Cerminara C, Montanaro ML, Curatolo P, Seri S. Lamotrigine-induced seizure aggravation and negative myoclonus in idiopathic rolandic epilepsy. Neurology 2004; 63 (2) 373-375
- 15 Grosso S, Balestri M, Di Bartolo RM , et al. Oxcarbazepine and atypical evolution of benign idiopathic focal epilepsy of childhood. Eur J Neurol 2006; 13 (10) 1142-1145
- 16 Pavlidis E, Rubboli G, Nikanorova M, Kölmel MS, Gardella E. Encephalopathy with status epilepticus during sleep (ESES) induced by oxcarbazepine in idiopathic focal epilepsy in childhood. Funct Neurol 2015; 30 (2) 139-141
- 17 Montenegro MA, Guerreiro MM. Electrical status epilepticus of sleep in association with topiramate. Epilepsia 2002; 43 (11) 1436-1440
- 18 De Negri M, Baglietto MG, Battaglia FM, Gaggero R, Pessagno A, Recanati L. Treatment of electrical status epilepticus by short diazepam (DZP) cycles after DZP rectal bolus test. Brain Dev 1995; 17 (5) 330-333
- 19 Kramer U, Sagi L, Goldberg-Stern H, Zelnik N, Nissenkorn A, Ben-Zeev B. Clinical spectrum and medical treatment of children with electrical status epilepticus in sleep (ESES). Epilepsia 2009; 50 (6) 1517-1524
- 20 Bahi-Buisson N, Savini R, Eisermann M , et al. Misleading effects of clonazepam in symptomatic electrical status epilepticus during sleep syndrome. Pediatr Neurol 2006; 34 (2) 146-150
- 21 Lerman P, Lerman-Sagie T. Sulthiame revisited. J Child Neurol 1995; 10 (3) 241-242
- 22 Doose H, Baier WK, Ernst JP, Tuxhorn I, Völzke E. Benign partial epilepsy—treatment with sulthiame. Dev Med Child Neurol 1988; 30 (5) 683-684
- 23 Gross-Selbeck G. Treatment of “benign” partial epilepsies of childhood, including atypical forms. Neuropediatrics 1995; 26 (1) 45-50
- 24 Fejerman N, Caraballo R, Cersósimo R, Ferraro SM, Galicchio S, Amartino H. Sulthiame add-on therapy in children with focal epilepsies associated with encephalopathy related to electrical status epilepticus during slow sleep (ESES). Epilepsia 2012; 53 (7) 1156-1161
- 25 Kossoff EH, Boatman D, Freeman JM. Landau-Kleffner syndrome responsive to levetiracetam. Epilepsy Behav 2003; 4 (5) 571-575
- 26 Chhun S, Troude P, Villeneuve N , et al. A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: continuous spikes and waves during sleep is definitely a target. Seizure 2011; 20 (4) 320-325
- 27 Chen J, Cai F, Jiang L, Hu Y, Feng C. Levetiracetam efficacy in children with epilepsy with electrical status epilepticus in sleep. Epilepsy Behav 2015; 44: 73-77
- 28 Patry G, Lyagoubi S, Tassinari CA. Subclinical “electrical status epilepticus” induced by sleep in children. A clinical and electroencephalographic study of six cases. Arch Neurol 1971; 24 (3) 242-252
- 29 Inutsuka M, Kobayashi K, Oka M, Hattori J, Ohtsuka Y. Treatment of epilepsy with electrical status epilepticus during slow sleep and its related disorders. Brain Dev 2006; 28 (5) 281-286
- 30 Liukkonen E, Kantola-Sorsa E, Paetau R, Gaily E, Peltola M, Granström ML. Long-term outcome of 32 children with encephalopathy with status epilepticus during sleep, or ESES syndrome. Epilepsia 2010; 51 (10) 2023-2032
- 31 Caraballo RH, Cejas N, Chamorro N, Kaltenmeier MC, Fortini S, Soprano AM. Landau-Kleffner syndrome: a study of 29 patients. Seizure 2014; 23 (2) 98-104
- 32 Grosso S, Parisi P, Giordano L, di Bartolo R, Balestri P. Lacosamide efficacy in epileptic syndromes with continuous spike and waves during slow sleep (CSWS). Epilepsy Res 2014; 108 (9) 1604-1608
- 33 Fine AL, Wirrell EC, Wong-Kisiel LC, Nickels KC. Acetazolamide for electrical status epilepticus in slow-wave sleep. Epilepsia 2015; 56 (9) e134-e138
- 34 Buzatu M, Bulteau C, Altuzarra C, Dulac O, Van Bogaert P. Corticosteroids as treatment of epileptic syndromes with continuous spike-waves during slow-wave sleep. Epilepsia 2009; 50 (Suppl. 07) 68-72
- 35 van den Munckhof B, van Dee V, Sagi L , et al. Treatment of electrical status epilepticus in sleep: a pooled analysis of 575 cases. Epilepsia 2015; 56 (11) 1738-1746
- 36 Mikati MA, Saab R, Fayad MN, Choueiri RN. Efficacy of intravenous immunoglobulin in Landau-Kleffner syndrome. Pediatr Neurol 2002; 26 (4) 298-300
- 37 Fejerman N, Tenembaum S, Medina CS. Continuous spike-waves during slow-wave sleep and awake in a case of childhood epilepsy with occipital paroxysms: clinical correlations. Epilepsia 1991; 32 (Suppl. 01) 16
- 38 Tenembaum SN, Deonna T, Fejerman N, Medina C, Ingvar-Maeder M, Gubser Mercati D. Continuous spike-waves and dementia in childhood epilepsy with occipital paroxysms. J Epilepsy 1997; 10 (3) 139-145
- 39 Arts WF, Aarsen FK, Scheltens-de Boer M, Catsman-Berrevoets CE. Landau-Kleffner syndrome and CSWS syndrome: treatment with intravenous immunoglobulins. Epilepsia 2009; 50 (Suppl. 07) 55-58
- 40 Fainberg N, Harper A, Tchapyjnikov D, Mikati MA. Response to immunotherapy in a patient with Landau-Kleffner syndrome and GRIN2A mutation. Epileptic Disord 2016; 18 (1) 97-100
- 41 Nikanorova M, Miranda MJ, Atkins M, Sahlholdt L. Ketogenic diet in the treatment of refractory continuous spikes and waves during slow sleep. Epilepsia 2009; 50 (5) 1127-1131
- 42 Reyes G, Flesler S, Armeno M , et al. Ketogenic diet in patients with epileptic encephalopathy with electrical status epilepticus during slow sleep. Epilepsy Res 2015; 113: 126-131
- 43 Morrell F, Whisler WW, Smith MC , et al. Landau-Kleffner syndrome. Treatment with subpial intracortical transection. Brain 1995; 118 (Pt 6): 1529-1546
- 44 Morrell F, Whisler WW, Smith MC. Clinical outcome in Landau-Kleffner syndrome treated by multiple subpial transection. Epilepsia 1992; 33 (Suppl. 03) 100
- 45 Irwin K, Birch V, Lees J , et al. Multiple subpial transection in Landau-Kleffner syndrome. Dev Med Child Neurol 2001; 43 (4) 248-252
- 46 Downes M, Greenaway R, Clark M , et al. Outcome following multiple subpial transection in Landau-Kleffner syndrome and related regression. Epilepsia 2015; 56 (11) 1760-1766
- 47 Park YD. The effects of vagus nerve stimulation therapy on patients with intractable seizures and either Landau-Kleffner syndrome or autism. Epilepsy Behav 2003; 4 (3) 286-290
- 48 Fernández IS, Chapman KE, Peters JM , et al. The tower of Babel: survey on concepts and terminology in electrical status epilepticus in sleep and continuous spikes and waves during sleep in North America. Epilepsia 2013; 54 (4) 741-750
- 49 Kramer U, Zelnik N, Lerman-Sagie T, Shahar E. Benign childhood epilepsy with centrotemporal spikes: clinical characteristics and identification of patients at risk for multiple seizures. J Child Neurol 2002; 17 (1) 17-19
- 50 Massa R, de Saint-Martin A, Carcangiu R , et al. EEG criteria predictive of complicated evolution in idiopathic rolandic epilepsy. Neurology 2001; 57 (6) 1071-1079
- 51 Capovilla G, Beccaria F, Veggiotti P, Rubboli G, Meletti S, Tassinari CA. Ethosuximide is effective in the treatment of epileptic negative myoclonus in childhood partial epilepsy. J Child Neurol 1999; 14 (6) 395-400
- 52 Fejerman N, Di Blasi AM. Status epilepticus of benign partial epilepsies in children: report of two cases. Epilepsia 1987; 28 (4) 351-355
- 53 Caraballo RH, Yépez II, Soprano AL, Cersósimo RO, Medina C, Fejerman N. Acquired epileptic aphasia [in Spanish]. Rev Neurol 1999; 29 (10) 899-907
- 54 Lagae LG, Silberstein J, Gillis PL, Casaer PJ. Successful use of intravenous immunoglobulins in Landau-Kleffner syndrome. Pediatr Neurol 1998; 18 (2) 165-168
- 55 Fejerman N, Caraballo R. Atypical Evolutions of Idiopathic Focal Epilepsies in Childhood. Journal of Pediatr Epilepsy 2016; 5 (3) 115